|
⚲
|
| Keyboard |
| Skaletsky Mark B
✚
|
|
|---|---|
| CIK # | 0001073379 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001073379] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alkermes PLC | |
| Skaletsky Mark B | |
| GYRE Therapeutics Inc | |
| ImmunoGen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alkermes PLC ALKS
Non Qualified Stock Option (Right to Buy) · derivative
|
2013-08-01 | Grant | 25,000 | $0.00 | |
|
GYRE Therapeutics Inc TRGT
Stock Option (Right to Buy) · derivative
|
2013-06-07 | Grant | 17,500 | $0.00 | |
|
ImmunoGen Inc IMGN
Deferred Share Unit · derivative
|
2012-11-13 | Grant | 2,626 | $0.00 | |
|
ImmunoGen Inc IMGN
Stock option (right to buy) · derivative
|
2012-11-13 | Grant | 4,645 | $11.42 | 53,046 |
|
Alkermes PLC ALKS
Non Qualified Stock Option (Right to Buy) · derivative
|
2012-08-01 | Grant | 25,000 | $0.00 | |
|
GYRE Therapeutics Inc TRGT
Stock Option (Right to Buy) · derivative
|
2012-06-11 | Grant | 57,500 | $0.00 |